13F HOLDINGS REPORT (Amended)
Sofinnova Investments, Inc.
Quarter ended Q2 2024 · Filed August 15, 2024 · Accession 0001104659-24-090054
Total Value
$1.79B
Positions
64
Other Managers
0
Confidential Omitted
No
Holdings (64)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Karuna Therapeutics Inc | 48576A100 | 1,380,466 | $436.9M | 24.44% |
| 2 | RayzeBio Inc | 75525N107 | 2,419,528 | $150.4M | 8.41% |
| 3 | Natera Inc | NTRA | 1,550,280 | $97.1M | 5.43% |
| 4 | Ascendis Pharma A/S | ASND | 754,032 | $95.0M | 5.31% |
| 5 | Merck & Co Inc | MRK | 857,971 | $93.5M | 5.23% |
| 6 | Aerovate Therapeutics Inc | 008064107 | 3,758,686 | $85.1M | 4.76% |
| 7 | AstraZeneca PLC | AZN | 850,577 | $57.3M | 3.20% |
| 8 | Vera Therapeutics Inc | VERA | 3,467,156 | $53.3M | 2.98% |
| 9 | IDEAYA Biosciences Inc | IDYA | 1,458,881 | $51.9M | 2.90% |
| 10 | ImmunoGen Inc | 45253H101 | 1,546,902 | $45.9M | 2.57% |
| 11 | Intuitive Surgical Inc | ISRG | 126,959 | $42.8M | 2.40% |
| 12 | Eli Lilly & Co | LLY | 64,525 | $37.6M | 2.10% |
| 13 | Cytokinetics Inc | CYTK | 414,207 | $34.6M | 1.93% |
| 14 | Celldex Therapeutics Inc | CLDX | 844,008 | $33.5M | 1.87% |
| 15 | CymaBay Therapeutics Inc | 23257D103 | 1,411,769 | $33.3M | 1.87% |
| 16 | Immatics NV | IMTX | 2,969,039 | $31.3M | 1.75% |
| 17 | Sanofi | SNYNF | 598,978 | $29.8M | 1.67% |
| 18 | Inhibrx Inc | INBX | 772,957 | $29.4M | 1.64% |
| 19 | Kenvue Inc | KVUE | 1,206,939 | $26.0M | 1.45% |
| 20 | Kura Oncology Inc | KURA | 1,667,321 | $24.0M | 1.34% |
| 21 | Syndax Pharmaceuticals Inc | SNDX | 1,075,786 | $23.2M | 1.30% |
| 22 | Marinus Pharmaceuticals Inc | 56854Q200 | 1,772,699 | $19.3M | 1.08% |
| 23 | Stryker Corporation | SYK | 62,788 | $18.8M | 1.05% |
| 24 | Incyte Corp | INCY | 296,569 | $18.6M | 1.04% |
| 25 | Geron Corp | GERN | 8,814,497 | $18.6M | 1.04% |
| 26 | Inozyme Pharma Inc | 45790W108 | 4,280,308 | $18.2M | 1.02% |
| 27 | Elanco Animal Health Inc | ELAN | 1,193,885 | $17.8M | 1.00% |
| 28 | argenx SE | ARGX | 44,721 | $17.0M | 0.95% |
| 29 | Y-mAbs Therapeutics Inc | 984241109 | 2,194,278 | $15.0M | 0.84% |
| 30 | Pharvaris N V | PHVS | 510,441 | $14.3M | 0.80% |
| 31 | Dyne Therapeutics Inc | DYN | 1,013,505 | $13.5M | 0.75% |
| 32 | Agenus Inc | AGEN | 15,656,234 | $13.0M | 0.73% |
| 33 | Savara Inc | SVRA | 2,382,835 | $11.2M | 0.63% |
| 34 | Mirum Pharmaceuticals Inc | MIRM | 352,397 | $10.4M | 0.58% |
| 35 | Cabaletta Bio Inc | CABA | 429,395 | $9.7M | 0.55% |
| 36 | Immunovant Inc | IMVT | 222,553 | $9.4M | 0.52% |
| 37 | Boston Scientific Corp | BSX | 131,000 | $7.6M | 0.42% |
| 38 | Structure Therapeutics Inc | GPCR | 174,838 | $7.1M | 0.40% |
| 39 | MoonLake Immunotherapeutics | MLTX | 113,757 | $6.9M | 0.38% |
| 40 | Insulet Corp | PODD | 19,000 | $4.1M | 0.23% |
| 41 | Ironwood Pharmaceuticals Inc | IRWD | 331,099 | $3.8M | 0.21% |
| 42 | Bolt Biotherapeutics Inc | BOLT | 2,754,437 | $3.1M | 0.17% |
| 43 | Nextcure Inc | NXTC | 2,671,856 | $3.0M | 0.17% |
| 44 | Dexcom Inc | DXCM | 20,000 | $2.5M | 0.14% |
| 45 | Cooper Cos Inc | 216648402 | 4,000 | $1.5M | 0.08% |
| 46 | Masimo Corp | MASI | 12,800 | $1.5M | 0.08% |
| 47 | Nucana PLC | NCNA | 4,684,120 | $1.4M | 0.08% |
| 48 | Agenus Inc | AGEN | 1,600,000 | $1.3M | 0.07% |
| 49 | Fusion Pharmaceuticals Inc | 36118A100 | 117,099 | $1.1M | 0.06% |
| 50 | Marinus Pharmaceuticals Inc | 56854Q200 | 100,000 | $1.1M | 0.06% |
| 51 | Immatics NV | IMTX | 318,372 | $929,646 | 0.05% |
| 52 | Ikena Oncology Inc | 45175G108 | 363,479 | $716,054 | 0.04% |
| 53 | Nucana PLC | NCNA | 2,400,000 | $709,920 | 0.04% |
| 54 | PDS Biotechnology Corp | PDSB | 142,635 | $708,896 | 0.04% |
| 55 | Penumbra Inc | PEN | 2,000 | $503,080 | 0.03% |
| 56 | Galera Therapeutics Inc | GRTX | 3,083,712 | $448,372 | 0.03% |
| 57 | Karuna Therapeutics Inc | 48576A100 | 683 | $216,176 | 0.01% |
| 58 | Fulcrum Therapeutics Inc | FULC | 28,600 | $193,050 | 0.01% |
| 59 | PepGen Inc | PEPG | 23,038 | $156,658 | 0.01% |
| 60 | Establishment Labs Hldgs Inc | ESTA | 3,052 | $79,016 | 0.00% |
| 61 | Fusion Pharmaceuticals Inc | 36118A100 | 8,200 | $78,802 | 0.00% |
| 62 | Spruce Biosciences Inc | SPRB | 22,767 | $66,707 | 0.00% |
| 63 | Soleno Therapeutics Inc | SLNO | 1,200 | $48,300 | 0.00% |
| 64 | Vir Biotechnology Inc | VIR | 4,495 | $45,220 | 0.00% |